Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/50495

Type
Preprint
Copyright
Open access
Sustainable Development Goals
01 Erradicação da pobreza
03 Saúde e Bem-Estar
10 Redução das desigualdades
 
Collections
Share

Statistics
Metadata
Show full item record

GLOBAL DISPARITIES IN SKIN CANCER SERVICES AT HIV TREATMENT CENTERS ACROSS 29 COUNTRIES
McMahon, Devon E. et al. | Date Issued: 2021
Author
McMahon, Devon E.
Semeere, Aggrey
Laker-Oketta, Miriam
Byakwaga, Helen
Mugglin, Catrina
Duda, Stephany N.
Azwa, Iskandar
Jaquet, Antoine
Cardoso, Sandra W.
Nash, Denis
Wester, C. William
Freeman, Esther E.
Affilliation
Harvard Medical School. Massachusetts General Hospital. Department of Dermatology. Boston, Massachusetts, USA.
Makerere University. College of Health Sciences. Infectious Diseases Institute. Kampala, Uganda.
Makerere University. College of Health Sciences. Infectious Diseases Institute. Kampala, Uganda.
Makerere University. College of Health Sciences. Infectious Diseases Institute. Kampala, Uganda.
University of Bern. Institute of Social and Preventative Medicine. Bern, Switzerland.
Vanderbilt University Medical Center. Nashville, Tennessee, USA.
University of Malaya Medical Center. Faculty of Medicine. Infectious Diseases Unit. Kuala Lumpur, Malaysia.
University of Bordeaux. French National Research Institute for Sustainable Development. Bordeaux, France.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
The City University of New York. Department of Epidemiology and Biostatistics. New York, NY, USA.
Vanderbilt University Medical Center. Nashville, Tennessee, USA.
Harvard Medical School. Massachusetts General Hospital. Department of Dermatology. Boston, Massachusetts, USA.
Abstract
More than two thirds of global cancer deaths occur in LMICs due in part to delayed diagnosis and lack of access to specialized staff, chemotherapy and radiation.(Livingston, 2013) Cutaneous malignancies are common and morbid in LMICs, particularly for people living with HIV.(Bray et al., 2018, McMahon et al., 2020) People living with HIV develop more AIDS-defining and non-AIDS defining skin cancers compared to the general population, including Kaposi sarcoma (KS), human papillomavirus (HPV)-associated squamous cell carcinomas, cutaneous lymphoma, keratinocyte carcinomas and melanoma.(Chelidze et al., 2019, Jaquet et al., 2015, WHO, 2014) KS in particular continues to be the leading cause of cancer incidence and mortality across the general population of Malawi, Mozambique, Uganda, and Zambia.(Bray et al., 2018) Although the majority of people living with HIV reside in LMICs – including 25.6 million people in sub-Saharan Africa – little is known about LMIC capacity to diagnose and manage skin cancers.
Keywords
HIV
Skin Cancer
Dermatology
Pathology
Biopsy
Diagnosis
Treatment
Low-Income population
Global health
 
Publisher
Elsevier
Later version
https://www.arca.fiocruz.br/handle/icict/64956
Citation
MCMAHON, Devon E. et al. Global disparities in skin cancer services at HIV treatment centers across 29 countries. The Journal of Investigative Dermatology, v. 141, n. 10, p. 2533-2536, Oct. 2021.
DOI
10.1016/j.jid.2021.02.758
ISSN
0022-202X